Springy synthetic cells supercharge T-cell immune response
UCLA Samueli School Of Engineering - 25-Nov-2024UCLA unveils viscoelastic antigen mimics to boost immunity and fight cancer
Join the club for FREE to access the whole archive and other member benefits.
UCLA unveils viscoelastic antigen mimics to boost immunity and fight cancer
Therapies targeting senescence cells show promise for controlling cancer progression
Targeted drug delivery and immune boost for personalized cancer therapy
Experts believe expanding this initiative could help save more lives
In trials on mice, the drug reduced tumors, promising new cancer treatments
New tech at NHS trusts speeds up cancer detection in high-risk areas
Tailored drug dosing could reduce harmful reactions for cancer patients
Unravelling tumour dynamics to enhance cancer treatment
A new trial offers hope for glioblastoma patients as innovative treatment yields significant results
Study suggests a healthy diet may reduce the risk of cancer advancing during active surveillance
The technology extends survival for some patients by 3.3 months
New funding accelerates the development of a novel neutrophil-based solid tumour treatment
Innovative £120 test could identify 12 common cancers, revolutionizing patient care and saving lives
Clinical trial shows treatment extends survival for patients with advanced lung cancer by over 40%
Scientists aim to harness the immune system to fight cancer in its earliest stages
New research highlights the role of gum disease-related microbes in increasing cancer susceptibility
Findings cover brain and head cancers, hinting mobile phones might be safe
Aston university creates a non-invasive test that detects prostate cancer in minutes
New stem cell breakthrough offers personalized cancer treatment with less rejection risk
Newly discovered protein may lead to cancer vaccines and advanced DNA repair
New mRNA-based vaccine takes center stage in promising lung cancer care
This has led to better early cancer detection and improved patient care
Researchers developed a "CD3 Score" to measure immune cell levels in tumours
C the Signs spots hidden patterns in patient records, leading to faster and early cancer diagnoses
The system works by being activated in acidic tumour environments